5-Chloro-3-nitropyrazolo[1,5-a]pyrimidine
CAS: 1363380-51-1
Ref. 3D-FC164744
10g | 194,00 € | ||
25g | 310,00 € | ||
50g | 436,00 € | ||
100g | 582,00 € |
Información del producto
Larotrectinib is a drug used to treat a type of cancer called TRK fusion cancers. This drug has been shown to be effective in vitro and in vivo by inhibiting the growth of tumour cells with mutant TRK fusions. Larotrectinib binds competitively to the ATP-binding site of the TRK receptor, blocking its activation by ATP. Larotrectinib has been shown to inhibit the proliferation of cells with mutant TRK fusions in culture and in animal models, including a mouse model for human breast cancer.
Propiedades químicas
Consulta técnica sobre: 3D-FC164744 5-Chloro-3-nitropyrazolo[1,5-a]pyrimidine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.